vs
Paramount Skydance Corporation(PSKY)与TENET HEALTHCARE CORP(THC)财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是Paramount Skydance Corporation的1.3倍($5.5B vs $4.1B),TENET HEALTHCARE CORP净利率更高(11.7% vs -0.3%,领先12.0%),TENET HEALTHCARE CORP同比增速更快(9.0% vs -38.8%),TENET HEALTHCARE CORP自由现金流更多($367.0M vs $222.0M)
派拉蒙天空之舞是美国跨国传媒娱乐集团,总部坐落于加利福尼亚州洛杉矶市好莱坞的派拉蒙影业园区内,旗下多家派拉蒙业务分支、子公司及核心办公会议场所均设于纽约阿斯特广场一号的原派拉蒙全球总部大楼。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业,旗下拥有USPI等多个品牌、子公司、合资企业及合作主体,运营65家医院及超过450个医疗设施,还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
PSKY vs THC — 直观对比
营收规模更大
THC
是对方的1.3倍
$4.1B
营收增速更快
THC
高出47.7%
-38.8%
净利率更高
THC
高出12.0%
-0.3%
自由现金流更多
THC
多$145.0M
$222.0M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $4.1B | $5.5B |
| 净利润 | $-13.0M | $644.0M |
| 毛利率 | — | — |
| 营业利润率 | 5.9% | 15.4% |
| 净利率 | -0.3% | 11.7% |
| 营收同比 | -38.8% | 9.0% |
| 净利润同比 | -1400.0% | 12.6% |
| 每股收益(稀释后) | $-0.01 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PSKY
THC
| Q4 25 | — | $5.5B | ||
| Q3 25 | $4.1B | $5.3B | ||
| Q2 25 | $0 | $5.3B | ||
| Q1 25 | $0 | $5.2B | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | $6.7B | $5.1B | ||
| Q2 24 | $0 | $5.1B | ||
| Q1 24 | — | $5.4B |
净利润
PSKY
THC
| Q4 25 | — | $644.0M | ||
| Q3 25 | $-13.0M | $579.0M | ||
| Q2 25 | $0 | $522.0M | ||
| Q1 25 | $0 | $622.0M | ||
| Q4 24 | — | $572.0M | ||
| Q3 24 | $1.0M | $681.0M | ||
| Q2 24 | $0 | $477.0M | ||
| Q1 24 | — | $2.3B |
营业利润率
PSKY
THC
| Q4 25 | — | 15.4% | ||
| Q3 25 | 5.9% | 16.8% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 16.2% | ||
| Q3 24 | 5.0% | 21.3% | ||
| Q2 24 | — | 14.9% | ||
| Q1 24 | — | 61.2% |
净利率
PSKY
THC
| Q4 25 | — | 11.7% | ||
| Q3 25 | -0.3% | 10.9% | ||
| Q2 25 | — | 9.9% | ||
| Q1 25 | — | 11.9% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | 0.0% | 13.3% | ||
| Q2 24 | — | 9.3% | ||
| Q1 24 | — | 43.5% |
每股收益(稀释后)
PSKY
THC
| Q4 25 | — | $4.22 | ||
| Q3 25 | $-0.01 | $3.86 | ||
| Q2 25 | $0.00 | $3.14 | ||
| Q1 25 | $0.00 | $4.27 | ||
| Q4 24 | — | $3.79 | ||
| Q3 24 | $0.00 | $4.89 | ||
| Q2 24 | $0.00 | $2.64 | ||
| Q1 24 | — | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.3B | $2.9B |
| 总债务越低越好 | $13.3B | $13.1B |
| 股东权益账面价值 | $12.0B | $4.2B |
| 总资产 | $43.2B | $29.7B |
| 负债/权益比越低杠杆越低 | 1.11× | 3.10× |
8季度趋势,按日历期对齐
现金及短期投资
PSKY
THC
| Q4 25 | — | $2.9B | ||
| Q3 25 | $3.3B | $3.0B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.5B |
总债务
PSKY
THC
| Q4 25 | — | $13.1B | ||
| Q3 25 | $13.3B | $13.1B | ||
| Q2 25 | — | $13.1B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $12.8B | ||
| Q1 24 | — | $12.8B |
股东权益
PSKY
THC
| Q4 25 | — | $4.2B | ||
| Q3 25 | $12.0B | $4.0B | ||
| Q2 25 | $0 | $3.7B | ||
| Q1 25 | $0 | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | $17.1B | $3.8B | ||
| Q2 24 | $0 | $3.5B | ||
| Q1 24 | — | $3.5B |
总资产
PSKY
THC
| Q4 25 | — | $29.7B | ||
| Q3 25 | $43.2B | $29.4B | ||
| Q2 25 | $0 | $28.7B | ||
| Q1 25 | $0 | $29.2B | ||
| Q4 24 | — | $28.9B | ||
| Q3 24 | — | $29.4B | ||
| Q2 24 | — | $29.3B | ||
| Q1 24 | — | $28.9B |
负债/权益比
PSKY
THC
| Q4 25 | — | 3.10× | ||
| Q3 25 | 1.11× | 3.26× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | 3.13× | ||
| Q4 24 | — | 3.14× | ||
| Q3 24 | — | 3.33× | ||
| Q2 24 | — | 3.67× | ||
| Q1 24 | — | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $268.0M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $222.0M | $367.0M |
| 自由现金流率自由现金流/营收 | 5.4% | 6.6% |
| 资本支出强度资本支出/营收 | 1.1% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势,按日历期对齐
经营现金流
PSKY
THC
| Q4 25 | — | $731.0M | ||
| Q3 25 | $268.0M | $1.1B | ||
| Q2 25 | $0 | $936.0M | ||
| Q1 25 | $0 | $815.0M | ||
| Q4 24 | — | $-331.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $0 | $747.0M | ||
| Q1 24 | — | $586.0M |
自由现金流
PSKY
THC
| Q4 25 | — | $367.0M | ||
| Q3 25 | $222.0M | $778.0M | ||
| Q2 25 | — | $743.0M | ||
| Q1 25 | — | $642.0M | ||
| Q4 24 | — | $-661.0M | ||
| Q3 24 | — | $829.0M | ||
| Q2 24 | — | $602.0M | ||
| Q1 24 | — | $346.0M |
自由现金流率
PSKY
THC
| Q4 25 | — | 6.6% | ||
| Q3 25 | 5.4% | 14.7% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | -13.0% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 6.4% |
资本支出强度
PSKY
THC
| Q4 25 | — | 6.6% | ||
| Q3 25 | 1.1% | 5.3% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 4.5% |
现金转化率
PSKY
THC
| Q4 25 | — | 1.14× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | — | 1.31× | ||
| Q4 24 | — | -0.58× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PSKY
| Affiliate And Subscription | $2.0B | 49% |
| Advertising | $1.3B | 31% |
| Licensing And Other | $775.0M | 19% |
| Related Party | $40.0M | 1% |
| Theatrical | $39.0M | 1% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |